Compumedics Limited (CMP.AX)
AUD 0.26
(0.0%)
AUD 0.26
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 5.08 Million AUD | 17.97% |
| 2023 | 5.66 Million AUD | 859.92% |
| 2022 | -746 Thousand AUD | 21.47% |
| 2021 | -950 Thousand AUD | 41.1% |
| 2020 | -1.61 Million AUD | 46.34% |
| 2019 | -3 Million AUD | -49.18% |
| 2018 | -2.01 Million AUD | 40.51% |
| 2017 | -3.38 Million AUD | -592.64% |
| 2016 | -489 Thousand AUD | -114.47% |
| 2015 | -228 Thousand AUD | -123.68% |
| 2014 | 963 Thousand AUD | -8.02% |
| 2013 | 1.04 Million AUD | 6.51% |
| 2012 | 983 Thousand AUD | -38.64% |
| 2011 | 1.6 Million AUD | 1383.33% |
| 2010 | 108 Thousand AUD | 202.86% |
| 2009 | -105 Thousand AUD | -104.79% |
| 2008 | 2.19 Million AUD | -29.01% |
| 2007 | 3.08 Million AUD | -1.28% |
| 2006 | 3.12 Million AUD | 55.16% |
| 2005 | 2.01 Million AUD | 185.85% |
| 2004 | -2.34 Million AUD | -1718.6% |
| 2003 | -129 Thousand AUD | -4.88% |
| 2002 | -123 Thousand AUD | 98.76% |
| 2001 | -9.92 Million AUD | 13.18% |
| 2000 | -11.42 Million AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 5.55 Million AUD | 0.0% |
| 2024 FY | 6.68 Million AUD | 17.83% |
| 2024 Q4 | 5.08 Million AUD | 0.0% |
| 2023 Q4 | 5.66 Million AUD | 0.0% |
| 2023 FY | 5.66 Million AUD | 859.92% |
| 2023 Q2 | 4.14 Million AUD | 0.0% |
| 2022 Q4 | -746 Thousand AUD | 0.0% |
| 2022 FY | -746 Thousand AUD | 21.47% |
| 2022 Q2 | -1.37 Million AUD | 0.0% |
| 2021 FY | -950 Thousand AUD | 41.1% |
| 2021 Q4 | -950 Thousand AUD | 0.0% |
| 2021 Q2 | -575 Thousand AUD | 0.0% |
| 2020 FY | -1.61 Million AUD | 46.34% |
| 2020 Q2 | 616 Thousand AUD | 0.0% |
| 2020 Q4 | -1.61 Million AUD | 0.0% |
| 2019 FY | -3 Million AUD | -49.18% |
| 2019 Q2 | -2.47 Million AUD | 0.0% |
| 2019 Q4 | -3 Million AUD | 0.0% |
| 2018 FY | -2.01 Million AUD | 40.51% |
| 2018 Q2 | -2.11 Million AUD | 0.0% |
| 2018 Q4 | -2.01 Million AUD | 0.0% |
| 2017 Q4 | -3.38 Million AUD | 0.0% |
| 2017 FY | -3.38 Million AUD | -592.64% |
| 2017 Q2 | -4.73 Million AUD | 0.0% |
| 2016 Q4 | -489 Thousand AUD | 0.0% |
| 2016 FY | -489 Thousand AUD | -114.47% |
| 2016 Q2 | 203 Thousand AUD | 0.0% |
| 2015 FY | -228 Thousand AUD | -123.68% |
| 2015 Q4 | -228 Thousand AUD | 0.0% |
| 2015 Q2 | 892 Thousand AUD | 0.0% |
| 2014 FY | 963 Thousand AUD | -8.02% |
| 2014 Q2 | 707 Thousand AUD | 0.0% |
| 2014 Q4 | 964 Thousand AUD | 0.0% |
| 2013 Q2 | -1.65 Million AUD | 0.0% |
| 2013 FY | 1.04 Million AUD | 6.51% |
| 2013 Q4 | 1.04 Million AUD | 0.0% |
| 2012 FY | 983 Thousand AUD | -38.64% |
| 2012 Q4 | 983 Thousand AUD | 0.0% |
| 2011 FY | 1.6 Million AUD | 1383.33% |
| 2011 Q4 | 1.6 Million AUD | 0.0% |
| 2010 FY | 108 Thousand AUD | 202.86% |
| 2010 Q4 | 110 Thousand AUD | 0.0% |
| 2009 FY | -105 Thousand AUD | -104.79% |
| 2009 Q4 | -106 Thousand AUD | 0.0% |
| 2008 FY | 2.19 Million AUD | -29.01% |
| 2008 Q4 | 2.19 Million AUD | 0.0% |
| 2007 FY | 3.08 Million AUD | -1.28% |
| 2007 Q4 | 3.04 Million AUD | 0.0% |
| 2006 FY | 3.12 Million AUD | 55.16% |
| 2006 Q4 | 3.12 Million AUD | 0.0% |
| 2005 Q4 | 2.04 Million AUD | 0.0% |
| 2005 FY | 2.01 Million AUD | 185.85% |
| 2004 Q4 | -2.29 Million AUD | 0.0% |
| 2004 FY | -2.34 Million AUD | -1718.6% |
| 2003 Q4 | -129.25 Thousand AUD | 0.0% |
| 2003 FY | -129 Thousand AUD | -4.88% |
| 2002 FY | -123 Thousand AUD | 98.76% |
| 2002 Q4 | -122.91 Thousand AUD | 0.0% |
| 2001 FY | -9.92 Million AUD | 13.18% |
| 2001 Q4 | -10.06 Million AUD | 0.0% |
| 2000 FY | -11.42 Million AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 119.96% |
| Adherium Limited | -6.1 Million AUD | 183.334% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 235.757% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 241.175% |
| Anteris Technologies Ltd | -28.49 Million AUD | 117.85% |
| Control Bionics Limited | -19.02 Thousand AUD | 26842.719% |
| CardieX Limited | 2.74 Million AUD | -85.23% |
| Cochlear Limited | -269.9 Million AUD | 101.885% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | -628.179% |
| Cyclopharm Limited | -7.49 Million AUD | 167.835% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 132.399% |
| Nova Eye Medical Limited | -2.8 Million AUD | 281.549% |
| HeraMED Limited | -799.34 Thousand AUD | 736.394% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 64.876% |
| ImpediMed Limited | -23.48 Million AUD | 121.657% |
| InhaleRx Limited | -155.54 Thousand AUD | 3370.457% |
| LBT Innovations Limited | -604 Thousand AUD | 942.219% |
| Micro-X Limited | 826.99 Thousand AUD | -515.116% |
| Neurotech International Limited | -2.11 Million AUD | 341.035% |
| OncoSil Medical Limited | -4.43 Million AUD | 214.812% |
| PolyNovo Limited | -30.52 Million AUD | 116.664% |
| Respiri Limited | 413.68 Thousand AUD | -1129.668% |
| SomnoMed Limited | -15.16 Million AUD | 133.549% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 195.91% |
| Uscom Limited | -1.53 Million AUD | 432.346% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 224.591% |